UK Exports to US Plunge 25 Following Trump Tariffs Resulting in Trade Deficit
BlueCollar Workers Emerge as Winners in AI Economy ATT CEO Says
Borosil Glass Works Shares Surge Over 200 in a Year Key Drivers Behind the Rally
Robinhood Unveils AI Agent Tools for Trading and Spending Targeting Retail Investors
Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project
Jim Cramer Weighs In on Atlassians YouTube Controversy What Investors Should Know
BATRK Q1 2026 Earnings Loss Narrows Surpasses Analyst Expectations
VOD Q4 2025 Earnings EPS Surges 408 Above Estimates Stock Edges Higher
PEBK Q4 2025 Earnings EPS of 121 Surpasses Absent Estimates Shares Edge Higher
REFR Q1 2026 Earnings Losses Continue with No Reported Revenue Stock Declines 066
Capstone Holding Corp CAPS Q4 2025 Earnings Massive EPS Miss Sends Stock Higher A Contradictory Market Reaction
UAN Q1 2026 Earnings Strong EPS of 472 Driven by Favorable Nitrogen Market Units Dip Slightly
TScan Therapeutics TCRX Rallies 39 as Shares Test Key Resistance Levels
Nuwellis Inc NUWE Drops Over 13 as Shares Approach Critical Support
Leapfrog Acquisition Corporation LFAC Holds Steady at 998 Amid Quiet Trading
Diamondback Energy FANG Slips 185 as Resistance Holds Support Levels in Focus
Stryker Corporation SYK Edges Higher as Price Holds Above Support Zone
Waymo Temporarily Expands Robotaxi Pause in Five US Cities After Flooded Road Incidents
BW Q1 2026 Earnings Wide EPS Miss Weighs on Investor Sentiment
SmartKem Inc SMTK Edges Higher MicroCap Stock Holds Above Key Support After Modest Gain
Enerpac Tool Group EPAC Edges Higher as Support Holds Steady
NCS Multistage Holdings NCSM Eases Slightly as Traders Eye Key Support and Resistance Levels
Circle Internet Group Inc CRCL Faces Resistance as Stock Pulls Back from Recent Highs
ATT T Edges Lower Navigating Support and Resistance Levels
Olaplex Holdings OLPX Holds Steady Near Support as Traders Eye Breakout Potential
BULLW Warrants Slide 954 as Webulls Equitylinked Securities Test Key Support
Nektar Therapeutics NKTR Navigates a 287 Decline as Key Support Levels Come Into Focus